← Every company

AbbVie Inc SEC Filings

What AbbVie Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

ABBV overview →
Filings on file
156
since Oct 14, 2016
Warning signs
2
latest Jan 10, 2025
Last results
Oct 5, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Oct 2, 2020
Merger vote or registration
S-4
Read ↗
May 14, 2020
Acquisition or sale completed
8-K/A
Read ↗
May 8, 2020
Executive or director changeAcquisition or sale completedNew debtUnregistered share sale
8-K
Read ↗
May 1, 2018
Tender offer
SC TO-I
Read ↗

Source: AbbVie Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on ABBV

Related datasets